About Amy Arnsten
The Arnsten Lab studies molecular influences on the higher cognitive functions of the prefrontal cortex (PFC), with the overarching goal of developing rational treatments for cognitive disorders and mental illness. The lab uses a multi-di
sciplinary approach to understand mechanisms influencing PFC cognition at the cellular and behavioral levels. Research has focused on how the catecholamines norepinephrine (NE) and dopamine (DA), powerfully and dynamically modulate PFC cognitive function
and physiology through intracellular signaling mechanisms. Our data explain how exposure to stress causes the rapid loss of PFC cognitive abilities, and how genetic mutations in molecules that regulate these pathways can lead to symptoms of mental illness
. Dysregulation of these pathways also contributes to cognitive decline with normal aging. Understanding these mechanisms has led to successful new treatments for patients with PFC dysfunction, including medications for Attention Deficit Hyperactivity Dis
order, Post-Traumatic Stress Disorder and a potential treatment for schizophrenia and bipolar disorder.

